Most Viewed Articles
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
Review ArticleReactive and proactive treatment in atopic dermatitis: Long-term disease controlFull text |  PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_31_2023 |
3,634 | 83,917 | 87,551 |
EditorialIndian Journal of Skin Allergy – Embracing new horizonsFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_39_2023 |
1,466 | 86,022 | 87,488 |
CommentaryStatus of research and publication in IndiaFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_29_2023 |
2,616 | 73,858 | 76,474 |
EditorialEczema and skin allergy-focus on researchFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_29_2024 |
1,542 | 60,695 | 62,237 |
Case ReportHair depigmentation in a patient treated with pazopanib: A case report and a comprehensive analysisFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_52_2023 |
3,385 | 44,576 | 47,961 |
Original ArticleEfficacy and safety of crisaborole ointment in pediatric atopic dermatitis: A 4-week open-label studyFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_45_2023 |
3,390 | 40,835 | 44,225 |
Letter to EditorMethotrexate in refractory chronic urticariaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_15_2024 |
2,182 | 39,313 | 41,495 |
Case ReportAmbroxol-induced leukocytoclastic vasculitis: A case report and literature reviewFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_37_2023 |
2,637 | 37,645 | 40,282 |
Review ArticleCutaneous adverse drug reactions in children with a focus on hypersensitivity to systemic drugs: A narrative reviewFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_14_2024 |
1,712 | 35,636 | 37,348 |
Original ArticleComorbidities in patients with chronic urticaria: A cross sectional study from an Urticaria Center of Reference and ExcellenceFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_26_2023 |
3,639 | 25,198 | 28,837 |
SymposiumInvestigations and treatment of photodermatosesFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_6_2024 |
2,776 | 21,318 | 24,094 |
Case ReportA novel pitch against the itchFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_13_2024 |
2,916 | 19,396 | 22,312 |
Case ReportPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_3_2024 |
2,732 | 19,461 | 22,193 |
Review ArticlePigmented contact dermatitis: An updated reviewFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_44_2023 |
6,178 | 14,920 | 21,098 |
ImageGiant fixed drug eruptionFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_47_2023 |
2,426 | 14,232 | 16,658 |
Letter to EditorPost-herpetic neuralgia-associated patchy hair loss closely mimicking trichotillomaniaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_19_2024 |
2,067 | 14,116 | 16,183 |
Original ArticleThe effectiveness of bilastine and fexofenadine updosing in the management of chronic spontaneous urticariaFull text | PDF Volume 1 | Issue 2 | July-December 2022DOI: 10.25259/IJSA_3_2021 |
12,392 | 3,269 | 15,661 |
SymposiumPhototoxicity and photoallergy – A brief review on pathogenesis, recent advances, and approach to a patient with photosensitivityFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_9_2024 |
3,868 | 11,570 | 15,438 |
Letter to EditorDasatinib-induced hand foot syndrome followed by bosutinib-induced photoallergic contact dermatitis in a patient of chronic myeloid leukemia: A rare co-occurrenceFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_1_2024 |
1,871 | 11,699 | 13,570 |
Letter to EditorHomemade lip injection for cosmetic purpose: A case reportFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_42_2023 |
1,685 | 11,837 | 13,522 |
Case ReportPenile angioedema in a child: A nightmare to parents!Full text | PDF Volume 1 | Issue 1 | January-June 2022DOI: 10.25259/IJSA_5_2021 |
9,944 | 2,934 | 12,878 |
Letter to EditorCutaneous vasculitis as the sole clinical feature of primary Sjögren’s syndromeFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_48_2023 |
2,901 | 9,330 | 12,231 |
SymposiumCutaneous photobiologyFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_11_2024 |
2,736 | 9,425 | 12,161 |
Review ArticleA review of comorbidities in atopic dermatitisFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_37_2024 |
3,768 | 7,866 | 11,634 |
Original ArticleImpact of atopic dermatitis on quality of life in children and their families: A tertiary care hospital-based study from Northern IndiaFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_5_2024 |
3,073 | 8,436 | 11,509 |
Original ArticleStudy of effectiveness of methotrexate oral pulse in refractory chronic urticariaFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_28_2023 |
2,505 | 8,871 | 11,376 |
Resident’s CornerAllergic reactions to radiocontrast media–A brief overviewFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_4_2024 |
2,072 | 9,081 | 11,153 |
Review ArticleStem-cell therapy in dermatology – Challenges and opportunitiesFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_50_2023 |
4,495 | 6,611 | 11,106 |
SymposiumPolymorphous light eruptionsFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_8_2024 |
2,448 | 8,564 | 11,012 |
Case ReportSubacute cutaneous lupus erythematosus in a patient of pancreatic cancer secondary to novel albumin-bound paclitaxel chemotherapyFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_25_2023 |
1,801 | 9,198 | 10,999 |
Letter to EditorHeat urticaria – Characterizing the population from an urticaria center of reference and excellence (UCARE)Full text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_51_2023 |
2,732 | 8,048 | 10,780 |
Original ArticlePatch testing with Indian standard series of 20 allergens in 125 patients of chronic dermatitis and dermatosesFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_16_2024 |
4,212 | 6,377 | 10,589 |
Letter to EditorHot car seat thermal burn: A must sought for differential diagnosis in summersFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_31_2024 |
1,495 | 9,022 | 10,517 |
Review ArticleJAK inhibitors in dermatologyFull text | PDF Volume 2 | Issue 1 | January-June 2023DOI: 10.25259/IJSA_7_2021 |
7,428 | 2,895 | 10,323 |
SymposiumChronic actinic dermatitisFull text | PDF Volume 3 | Issue 1 | January-June 2024DOI: 10.25259/IJSA_10_2024 |
2,808 | 7,380 | 10,188 |
CommentaryFellowship and mentorship opportunities in allergic skin disorders for Indian dermatologistsFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_30_2023 |
2,060 | 7,724 | 9,784 |
Original ArticleAtopic dermatitis in teenagers and adults: Clinical features of a tertiary referral hospitalFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_21_2022 |
1,803 | 7,538 | 9,341 |
Letter to EditorTeledermatology trends during two waves of the COVID-19 pandemic – Experience from western RajasthanFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_21_2024 |
1,512 | 7,483 | 8,995 |
Author’s replyPembrolizumab-induced resolving papulosquamous eruption: An enigmatic presentation in a patient with renal cell carcinomaFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_41_2024 |
1,467 | 7,295 | 8,762 |
Case SeriesHand eczema associated with frequent hand washing and use of hand sanitizer during COVID-19 pandemic: A case seriesFull text | PDF Volume 1 | Issue 2 | July-December 2022DOI: 10.25259/IJSA_11_2021 |
3,923 | 3,146 | 7,069 |
Letter to EditorAre dermatologists a well-informed audience for artificial intelligence? A knowledge, attitude, and practice surveyFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_20_2024 |
1,836 | 5,198 | 7,034 |
Case ReportA rare case of diffuse penile phytocontact dermatitis caused by common greenbrierFull text | PDF Volume 2 | Issue 1 | January-June 2023DOI: 10.25259/IJSA_22_2022 |
3,668 | 3,064 | 6,732 |
Review ArticleBiomarkers of chronic spontaneous urticariaFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_14_2023 |
4,364 | 2,259 | 6,623 |
Review ArticleChronic inducible urticaria: Clinical presentation, diagnosis, and managementFull text | PDF Volume 1 | Issue 1 | January-June 2022DOI: 10.25259/IJSA_12_2021 |
4,031 | 1,945 | 5,976 |
Letter to EditorInducible urticaria or skin lesions induced by Nd: YAG laser?Full text | PDF Volume 4 | Issue 1 | January-June 2025DOI: 10.25259/IJSA_41_2023 |
2,486 | 3,278 | 5,764 |
Review ArticleDigital object identifier: What it is and why it matters?Full text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_20_2023 |
4,023 | 1,670 | 5,693 |
Letter to EditorComparative real-world clinical assessment of mometasone furoate 0.1% and fluticasone propionate 0.005% in the treatment of atopic dermatitisFull text | PDF Volume 1 | Issue 2 | July-December 2022DOI: 10.25259/IJSA_4_2022 |
3,411 | 2,245 | 5,656 |
ObituaryObituary – Professor Marcus Maurer (1966–2024)Full text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_47_2024 |
4,018 | 1,555 | 5,573 |
Letter to EditorVitamin D levels in patients with chronic spontaneous urticariaFull text | PDF Volume 2 | Issue 2 | Jul-Dec 2023DOI: 10.25259/IJSA_3_2023 |
3,096 | 2,305 | 5,401 |
Letter to EditorSymmetrical drug-related intertriginous and flexural exanthema without baboon syndrome due to paracetamol: An uncommon side effect of a common drug: A case report and a review of literatureFull text | PDF Volume 3 | Issue 2 | July-December 2024DOI: 10.25259/IJSA_30_2024 |
1,471 | 3,730 | 5,201 |
